Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by increased mortality associated with cardiometabolic disorders including dyslipidaemia, insulin resistance, and cachectic obesity. Tumour necrosis factor inhibitors and interleukin 6 receptor blocker licensed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tournadre, Anne, Pereira, Bruno, Dutheil, Fréderic, Giraud, Charlotte, Courteix, Daniel, Sapin, Vincent, Frayssac, Thomas, Mathieu, Sylvain, Malochet‐Guinamand, Sandrine, Soubrier, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566648/
https://www.ncbi.nlm.nih.gov/pubmed/28316139
http://dx.doi.org/10.1002/jcsm.12189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566648/
https://www.ncbi.nlm.nih.gov/pubmed/28316139
http://dx.doi.org/10.1002/jcsm.12189

Ejemplares similares